Skip to main content

Disparities Seen in Stroke Incidence for Indigenous, Non-Indigenous People

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 15, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Feb. 14, 2024 -- Disparities in stroke incidence are seen between Indigenous and non-Indigenous populations in countries with a very high Human Development Index (HDI), according to a review published online Feb. 14 in Neurology.

Anna H. Balabanski, M.B.B.S., Ph.D., from Monash University in Melbourne, Australia, and colleagues examined stroke incidence in Indigenous populations of countries with a very high HDI in a review of population-based stroke incidence studies published between 1990 and 2022 among Indigenous adult populations of developed countries. Twenty-four studies from seven countries met the inclusion criteria.

The researchers found that the age-standardized stroke incidence rate ratios were greater in Aboriginal and Torres Strait Islander Australians, American Indians, Sámi of Sweden/Norway, and Singaporean Malay than the respective non-Indigenous populations (1.7 to 3.2, 1.2, 1.08 to 2.14, and 1.7 to 1.9, respectively). Considerable heterogeneity was seen in design and risk for bias. Indigenous stakeholder involvement was rarely reported; few studies met any of the CONSIDER criteria for research among Indigenous populations.

"Our study could be used to inform future stroke epidemiologic research in Indigenous populations, undertaken in partnership with Indigenous Peoples, potentially expanding beyond developed countries, to facilitate capacity building for Indigenous researchers and health care providers, and to diminish stroke burden in their communities," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted February 2024

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.